Natraj Proteins Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 478683,
    "name": "Natraj Proteins",
    "stock_name": "Natraj Proteins",
    "full_name": "Natraj Proteins Ltd",
    "name_url": "stocks-analysis/natraj-proteins",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.80",
    "chg": 0.76,
    "chgp": "2.37%",
    "dir": 1,
    "prev_price": "32.04",
    "mcapval": "12.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530119,
    "symbol": "",
    "ind_name": "Edible Oil",
    "ind_code": 60,
    "indexname": "",
    "isin": "INE444D01016",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.07 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/natraj-proteins-478683-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Natraj Proteins falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-natraj-proteins-fallingrising-3712841",
        "imagepath": "",
        "date": "2025-11-18 21:47:47",
        "description": "As of 18-Nov, Natraj Proteins Ltd is experiencing a decline in its stock price, currently at 37.50, reflecting a decrease of 0.5, or 1.32%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 5.99% during this period. Additionally, it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. In terms of performance against benchmarks, the stock has shown a significant decline of 15.92% year-to-date, while the Sensex has increased by 8.36% in the same timeframe. There is a notable rise in investor participation, with delivery volume increasing by 62.08% compared to the 5-day average, indicating some interest despite the overall downward trend.\n\nBroader Market Context: In the short term, Natraj Proteins has underperformed relative to the Sensex, which has gained 0.96% over the past week whil..."
      },
      {
        "title": "Natraj Proteins Q2 FY26: Mounting Losses Deepen as Operating Margins Turn Severely Negative",
        "link": "https://www.marketsmojo.com/news/result-analysis/natraj-proteins-q2-fy26-mounting-losses-deepen-as-operating-margins-turn-severely-negative-3718969",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NatrajProteins_quaterlyResult_3718969.png",
        "date": "2025-11-18 17:00:00",
        "description": "Natraj Proteins Ltd., a micro-cap edible oil manufacturer with a market capitalisation of ₹16.00 crores, reported a widening quarterly loss in Q2 FY26, posting a net loss of ₹1.65 crores compared to a loss of ₹1.21 crores in Q1 FY26. The sequential deterioration of 36.36% underscores the mounting operational challenges facing the Madhya Pradesh-based company, which has struggled to maintain profitability despite modest revenue growth. Year-on-year, the loss widened from ₹1.01 crores in Q2 FY25, representing a 63.37% deterioration in bottom-line performance."
      },
      {
        "title": "Natraj Proteins Faces Financial Challenges Amidst Operational Efficiency Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natraj-proteins-financial-trend-improves-from-very-negative-to-negative-despite-declining-sales-3711558",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NatrajProteins_fintrenddot_3711558.png",
        "date": "2025-11-18 11:01:16",
        "description": "Natraj Proteins, a microcap in the edible oil sector, reported a negative financial performance for the quarter ending September 2025, with declining net sales and low quarterly PBDIT. Despite achieving its highest operating cash flow, the company faces significant challenges, reflected in its stock performance compared to the Sensex."
      },
      {
        "title": "Is Natraj Proteins overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-natraj-proteins-overvalued-or-undervalued-3709760",
        "imagepath": "",
        "date": "2025-11-18 08:20:48",
        "description": "As of 17 November 2025, the valuation grade for Natraj Proteins has moved from expensive to attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of -9.07, an EV to EBITDA of 34.42, and a Price to Book Value of 0.49, which highlight its low valuation compared to earnings and assets.\n\nIn comparison to peers, Gokul Agro has a PE ratio of 20.15 and an EV to EBITDA of 10.23, while Guj. Ambuja Exp shows a PE of 22.97 and an EV to EBITDA of 11.75, both of which are considerably higher than Natraj Proteins. This suggests that Natraj is trading at a discount relative to its peers in the edible oil industry. Despite recent underperformance against the Sensex, with a year-to-date return of -14.80% compared to the Sensex's 8.72%, the attractive valuation suggests potential for recovery and growth...."
      },
      {
        "title": "How has been the historical performance of Natraj Proteins?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-natraj-proteins-3698910",
        "imagepath": "",
        "date": "2025-11-13 23:16:01",
        "description": "Answer:\nThe historical performance of Natraj Proteins shows significant fluctuations in key financial metrics over the years.\n\nBreakdown:\nNatraj Proteins experienced a decline in net sales from 193.73 Cr in Mar'24 to 117.78 Cr in Mar'25, following a trend of decreasing sales since Mar'23 when it was 143.60 Cr. The total operating income mirrored this decline, dropping to 117.78 Cr in Mar'25 from 193.73 Cr in Mar'24. Raw material costs also decreased significantly, falling from 150.82 Cr in Mar'24 to 95.70 Cr in Mar'25. Despite this reduction in costs, the operating profit (PBDIT) turned positive at 1.61 Cr in Mar'25 after being negative in Mar'24. However, the company reported a profit before tax of -1.18 Cr in Mar'25, indicating ongoing challenges. The profit after tax also remained negative at -1.46 Cr. The total liabilities decreased from 77.83 Cr in Mar'24 to 58.63 Cr in Mar'25, while total assets also ..."
      }
    ],
    "total": 90,
    "sid": "478683",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/natraj-proteins-478683"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate Under Reg. 74 (5) Of SEBI (DP) Regulations 2018",
      "datetime": "15-Jan-2026",
      "details": "Certificate for compliance of Regulation 74(5) of the SEBI(DP) Regulations 2018 for the quarter ending 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Dec-2025",
      "details": "The window for trading in the shares of the company shall remain close from 1st January 2026 till the completion of 48 hours after declaration of unaudited financial results of the company for the quarter and nine months ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2025",
      "details": "Submission of Press clipping related to extract of Quarterly/ Half- yearly Unaudited Fiancial Result of the Company for the Quarter/ Half year ended 30th September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Natraj Proteins falling/rising?

2025-11-18 21:47:47

As of 18-Nov, Natraj Proteins Ltd is experiencing a decline in its stock price, currently at 37.50, reflecting a decrease of 0.5, or 1.32%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 5.99% during this period. Additionally, it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. In terms of performance against benchmarks, the stock has shown a significant decline of 15.92% year-to-date, while the Sensex has increased by 8.36% in the same timeframe. There is a notable rise in investor participation, with delivery volume increasing by 62.08% compared to the 5-day average, indicating some interest despite the overall downward trend. Broader Market Context: In the short term, Natraj Proteins has underperformed relative to the Sensex, which has gained 0.96% over the past week whil...

Natraj Proteins Q2 FY26: Mounting Losses Deepen as Operating Margins Turn Severely Negative

2025-11-18 17:00:00

Natraj Proteins Ltd., a micro-cap edible oil manufacturer with a market capitalisation of ₹16.00 crores, reported a widening quarterly loss in Q2 FY26, posting a net loss of ₹1.65 crores compared to a loss of ₹1.21 crores in Q1 FY26. The sequential deterioration of 36.36% underscores the mounting operational challenges facing the Madhya Pradesh-based company, which has struggled to maintain profitability despite modest revenue growth. Year-on-year, the loss widened from ₹1.01 crores in Q2 FY25, representing a 63.37% deterioration in bottom-line performance.

Natraj Proteins Faces Financial Challenges Amidst Operational Efficiency Gains

2025-11-18 11:01:16

Natraj Proteins, a microcap in the edible oil sector, reported a negative financial performance for the quarter ending September 2025, with declining net sales and low quarterly PBDIT. Despite achieving its highest operating cash flow, the company faces significant challenges, reflected in its stock performance compared to the Sensex.

Is Natraj Proteins overvalued or undervalued?

2025-11-18 08:20:48

As of 17 November 2025, the valuation grade for Natraj Proteins has moved from expensive to attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of -9.07, an EV to EBITDA of 34.42, and a Price to Book Value of 0.49, which highlight its low valuation compared to earnings and assets. In comparison to peers, Gokul Agro has a PE ratio of 20.15 and an EV to EBITDA of 10.23, while Guj. Ambuja Exp shows a PE of 22.97 and an EV to EBITDA of 11.75, both of which are considerably higher than Natraj Proteins. This suggests that Natraj is trading at a discount relative to its peers in the edible oil industry. Despite recent underperformance against the Sensex, with a year-to-date return of -14.80% compared to the Sensex's 8.72%, the attractive valuation suggests potential for recovery and growth....

How has been the historical performance of Natraj Proteins?

2025-11-13 23:16:01

Answer: The historical performance of Natraj Proteins shows significant fluctuations in key financial metrics over the years. Breakdown: Natraj Proteins experienced a decline in net sales from 193.73 Cr in Mar'24 to 117.78 Cr in Mar'25, following a trend of decreasing sales since Mar'23 when it was 143.60 Cr. The total operating income mirrored this decline, dropping to 117.78 Cr in Mar'25 from 193.73 Cr in Mar'24. Raw material costs also decreased significantly, falling from 150.82 Cr in Mar'24 to 95.70 Cr in Mar'25. Despite this reduction in costs, the operating profit (PBDIT) turned positive at 1.61 Cr in Mar'25 after being negative in Mar'24. However, the company reported a profit before tax of -1.18 Cr in Mar'25, indicating ongoing challenges. The profit after tax also remained negative at -1.46 Cr. The total liabilities decreased from 77.83 Cr in Mar'24 to 58.63 Cr in Mar'25, while total assets also ...

View All News